SynCo has a proven track record in the formulation, aseptic filling and lyophilization of a wide range of therapeutic and recombinant proteins. SynCo is experienced in both clinical and market supply, with batch sizes up to 20,000 vials. The standard range of vial sizes is between DIN2R and DIN20R.
Analytical quality control comprises the testing of raw materials, packaging materials, bulk solutions, in-process materials and finished product (drug product). SynCo’s personnel are trained in state-of-the-art analytical techniques.
The instruments SynCo employs are validated according to current guidelines, and SynCo’s selected methods of analysis meet all international requirements for each project stage. SynCo also supports its clients in IMPD and IND filling during the clinical stages of the project.
In parallel with clinical-phase support, SynCo assists its customers in reviewing and preparing the appropriate CMC documents required for international product registration. SynCo’s personnel has extensive knowledge of all the FDA and EMA requirements and will ensure an efficient and cost-effective approval process.
SynCo is also licensed to perform analytical testing of products (e.g. recombinant protein drug products) that are produced elsewhere.
If you are interested in learning more about SynCo’s recombinant protein aseptic filling services, please do not hesitate to contact us.